NASDAQ:ATHN - athenahealth Stock Price, Price Target & More

$143.25 -2.82 (-1.93 %)

(As of 04/23/2018 04:00 PM ET)

Previous Close$143.25

Today's Range$141.92 - $146.81

52-Week Range$95.01 - $158.66

Volume332,851 shs

Average Volume470,677 shs

Market Capitalization$5.86 billion

P/E Ratio91.24

Dividend YieldN/A

Beta1.13

About athenahealth (NASDAQ:ATHN)

athenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.

Receive ATHN News and Ratings via Email

Sign-up to receive the latest news and ratings for ATHN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified

Sub-IndustryHealth Care Technology

SectorMedical

SymbolNASDAQ:ATHN

CUSIP04685W10

Webwww.athenahealth.com

Phone617-402-1000

Debt

Debt-to-Equity Ratio0.32%

Current Ratio1.84%

Quick Ratio1.84%

Price-To-Earnings

Trailing P/E Ratio91.24

Forward P/E Ratio52.86

P/E Growth3.04

Sales & Book Value

Annual Sales$1.22 billion

Price / Sales4.71

Cash Flow$5.1771 per share

Price / Cash27.67

Book Value$19.78 per share

Price / Book7.24

Profitability

EPS (Most Recent Fiscal Year)$1.57

Net Income$53.10 million

Net Margins4.35%

Return on Equity9.21%

Return on Assets5.35%

Miscellaneous

Employees5,156

Outstanding Shares40,100,000

How to Become a New Pot Stock Millionaire

athenahealth (NASDAQ:ATHN) Frequently Asked Questions

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth (NASDAQ:ATHN) released its quarterly earnings results on Thursday, February, 1st. The health services provider reported $1.11 EPS for the quarter, topping the consensus estimate of $0.63 by $0.48. The health services provider earned $329.20 million during the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company's quarterly revenue was up 14.2% on a year-over-year basis. During the same period last year, the business posted $0.62 earnings per share. View athenahealth's Earnings History.

When is athenahealth's next earnings date?

athenahealth is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for athenahealth.

What price target have analysts set for ATHN?

25 Wall Street analysts have issued 1-year price targets for athenahealth's shares. Their predictions range from $88.00 to $186.00. On average, they anticipate athenahealth's share price to reach $144.3478 in the next twelve months. View Analyst Ratings for athenahealth.

What are Wall Street analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

1. Canaccord Genuity analysts commented, "We remain neutral on the stock until we get a better understanding of the restructuring initiatives, financial predictability, and the go-forward growth strategy. Pre-call takeaways: Upside to revenue, with significant bottom-line beat. Rev. of $329.2M (+14.2%) beat our est. $324.8M and cons. $320.0M, and came in at the high end of implied guidance range $309-$329M. Beats on adjusted gross margin and all expense line items enabled the company to post non-GAAP op. inc. of $77.6M (+82.6%), far surpassing us and cons. both near ~$45M and implied guidance of $38-53M. Adj-EPS of $1.11 also beat our est. $0.65 and cons. $0.63." (2/1/2018)
2. Cantor Fitzgerald analysts commented, "This morning, athenaHealth filed an 8-K indicating that it implemented a change in control severance plan for certain executives." (10/27/2017)

Who are some of athenahealth's key competitors?

Some companies that are related to athenahealth include Alliance Data (ADS), Zillow (Z), Zillow (ZG), Grubhub (GRUB), CDK Global (CDK), Western Union (WU), WEX (WEX), FICO (FICO), Maximus (MMS), Conduent (CNDT), Healthequity (HQY), Stamps.com (STMP), Etsy (ETSY), TriNet (TNET) and Ritchie Bros. Auctioneers (RBA).

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:

Mr. Jonathan J. Bush, Pres, CEO & Director (Age 49)
Mr. Timothy John O'Brien, Sr. VP of Commercial Operations & Chief Marketing Officer (Age 42)
Dr. Stephen N. Kahane M.D., M.S, Exec. Director of Client Organization (Age 60)
Mr. John A. Kane, Director (Age 65)
Mr. Marc A. Levine, Exec. VP, CFO, Treasurer & Principal Accounting Officer (Age 58)

Has athenahealth been receiving favorable news coverage?

News coverage about ATHN stock has been trending somewhat negative recently, Accern reports. Accern identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. athenahealth earned a coverage optimism score of -0.06 on Accern's scale. They also assigned news headlines about the health services provider an impact score of 44.77 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of athenahealth?

Shares of ATHN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of ATHN stock can currently be purchased for approximately $143.25.

How big of a company is athenahealth?

athenahealth has a market capitalization of $5.86 billion and generates $1.22 billion in revenue each year. The health services provider earns $53.10 million in net income (profit) each year or $1.57 on an earnings per share basis. athenahealth employs 5,156 workers across the globe.

How can I contact athenahealth?

athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]

MarketBeat Community Rating for athenahealth (ATHN)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		536 (Vote Outperform)
Underperform Votes:		588 (Vote Underperform)
Total Votes:		1,124

MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe ATHN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATHN will underperform the S&P 500 over the long term. You may vote once every thirty days.

athenahealth (NASDAQ:ATHN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

25 Wall Street analysts have issued ratings and price targets for athenahealth in the last 12 months. Their average twelve-month price target is $144.3478, suggesting that the stock has a possible upside of 0.77%. The high price target for ATHN is $186.00 and the low price target for ATHN is $88.00. There are currently 1 sell rating, 17 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.24	2.24	2.28	2.40
Ratings Breakdown:	1 Sell Rating(s) 17 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 17 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 16 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 13 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$144.3478	$144.3478	$142.9565	$144.3043
Price Target Upside:	0.77% upside	2.14% upside	13.88% upside	14.16% upside

athenahealth (NASDAQ:ATHN) Consensus Price Target History

Price Target History for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/27/2018	Bank of America	Initiated Coverage	Neutral -> Neutral	$147.00	Low
2/16/2018	Piper Jaffray	Reiterated Rating	Buy	$160.00	Low
2/15/2018	Royal Bank of Canada	Set Price Target	Hold	$141.00	Low
2/5/2018	SunTrust Banks	Boost Price Target	Buy	$180.00	High
2/1/2018	Canaccord Genuity	Boost Price Target	Hold -> Hold	$123.00 -> $137.00	High
1/18/2018	Evercore ISI	Initiated Coverage	In -> In-Line	$140.00	Medium
1/12/2018	KeyCorp	Reiterated Rating	Buy	$152.00	High
1/4/2018	Citigroup	Initiated Coverage	Neutral		Low
12/8/2017	Deutsche Bank	Initiated Coverage	Hold -> Hold	$145.00	High
10/27/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$120.00	N/A
10/23/2017	Leerink Swann	Lower Price Target	Market Perform	$155.00 -> $125.00	N/A
10/23/2017	Wells Fargo	Lower Price Target	Outperform	$190.00 -> $155.00	N/A
10/23/2017	First Analysis	Upgrade	Underweight -> Equal Weight	$125.00 -> $127.00	N/A
10/22/2017	Robert W. Baird	Lower Price Target	Outperform	$170.00 -> $155.00	N/A
10/20/2017	Oppenheimer	Reiterated Rating	Buy	$184.00	N/A
10/13/2017	Jefferies Group	Set Price Target	Hold	$120.00 -> $110.00	N/A
8/2/2017	Morgan Stanley	Reiterated Rating	Equal Weight	$108.00 -> $125.00	Low
7/31/2017	Cowen	Downgrade	Outperform -> Market Perform	$127.00 -> $133.00	Medium
7/24/2017	UBS	Reiterated Rating	Buy -> Positive	$157.00 -> $175.00	Low
7/21/2017	William Blair	Reiterated Rating	Market Perform		Medium
7/19/2017	JPMorgan Chase	Set Price Target	Hold	$136.00	Low
7/7/2017	Dougherty & Co	Downgrade	Buy -> Neutral		High
7/7/2017	Argus	Initiated Coverage	Hold		High
6/16/2017	Stifel Nicolaus	Reiterated Rating	Hold	$106.00 -> $151.00	Low
5/1/2017	Barclays	Set Price Target	Underweight	$97.00 -> $88.00	Medium
2/7/2017	Berenberg Bank	Initiated Coverage	Buy	$143.00	N/A
1/4/2017	Pacific Crest	Upgrade	Overweight	$140.00	N/A
7/22/2016	FBR & Co	Lower Price Target	Market Perform	$145.00 -> $140.00	N/A

(Data available from 4/23/2016 forward)

athenahealth (NASDAQ:ATHN) Earnings History and Estimates Chart

Earnings by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Earnings Estimates

2018 EPS Consensus Estimate: $1.41

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.22	$0.22	$0.22
Q2 2018	1	$0.33	$0.33	$0.33
Q3 2018	1	$0.34	$0.34	$0.34
Q4 2018	1	$0.52	$0.52	$0.52

athenahealth (NASDAQ ATHN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/25/2018		$0.58					N/A
2/1/2018	Q4 2017	$0.63	$1.11	$319.64 million	$329.20 million	View	Listen
10/19/2017	Q3 2017	$0.50	$0.56	$310.52 million	$304.60 million	View	N/A
7/20/2017	Q2 2017	$0.39	$0.51	$298.68 million	$301.10 million	View	N/A
4/27/2017	Q1 2017	$0.11	$0.10	$296.49 million	$285.40 million	View	N/A
2/2/2017	Q4 2016	$0.5080	$0.62	$303.72 million	$288.20 million	View	Listen
10/20/2016	Q3	$0.47	$0.60	$280.17 million	$276.67 million	View	Listen
7/21/2016	Q2	$0.42	$0.34	$274.07 million	$261.90 million	View	Listen
4/28/2016	Q1	$0.26	$0.34	$248.49 million	$256.15 million	View	Listen
2/4/2016	Q415	$0.41	$0.45	$257.68 million	$257.50 million	View	N/A
10/22/2015	Q315	$0.26	$0.36	$233.03 million	$236.10 million	View	Listen
7/23/2015	Q215	$0.25	$0.32	$227.08 million	$224.70 million	View	Listen
4/30/2015	Q115	($0.10)	$0.24	$205.24 million	$206.40 million	View	Listen
2/5/2015	Q414	$0.39	$0.58	$207.99 million	$213.20 million	View	N/A
10/16/2014	Q314	$0.27	$0.27	$190.40 million	$190.40 million	View	Listen
7/17/2014	Q214	$0.22	$0.32	$182.14 million	$185.90 million	View	N/A
4/17/2014	Q114	($0.01)	$0.12	$170.03 million	$163.00 million	View	Listen
2/6/2014	Q413	$0.45	$0.57	$168.39 million	$171.60 million	View	N/A
10/17/2013	Q313	$0.31	$0.29	$154.80 million	$151.50 million	View	N/A
7/18/2013	Q2 2013	$0.22	($0.08)	$148.24 million	$149.30 million	View	Listen
5/2/2013	Q1 2013	$0.23	$0.38	$121.05 million	$125.60 million	View	Listen
2/7/2013	Q4 2012	$0.28	$0.29	$116.97 million	$116.30 million	View	Listen
10/18/2012		$0.26	$0.30			View	N/A
7/19/2012		$0.23	$0.24			View	N/A
4/26/2012		$0.17	$0.17			View	N/A
2/15/2012		$0.23	$0.26			View	N/A
10/20/2011		$0.20	$0.24			View	N/A
7/21/2011		$0.19	$0.22			View	N/A
4/28/2011		$0.13	$0.17			View	N/A
2/17/2011		$0.20	$0.28			View	N/A
10/21/2010	Q3 2010	$0.08	$0.11			View	N/A
7/22/2010	Q2 2010	$0.06	$0.04			View	N/A
4/29/2010	Q1 2010	$0.10	$0.02			View	N/A
3/15/2010	Q4 2009	$0.12	$0.12			View	N/A
10/29/2009	Q3 2009	$0.10	$0.08			View	N/A
8/5/2009	Q2 2009	$0.09	$0.09			View	N/A
4/30/2009	Q1 2009	$0.10	$0.07			View	N/A
2/26/2009	Q4 2008	$0.13	$0.11			View	N/A
11/6/2008	Q3 2008	$0.09	$0.11			View	N/A
8/4/2008	Q2 2008	$0.07	$0.08			View	N/A
5/6/2008	Q1 2008	$0.06	$0.05			View	N/A
3/5/2008	Q4 2007	$0.06	$0.06			View	N/A

(Earnings results data provided by Zacks Investment Research)

athenahealth (NASDAQ:ATHN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

athenahealth (NASDAQ ATHN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.20%

Insider Trading History for athenahealth (NASDAQ:ATHN)

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ ATHN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2018	Jonathan Bush	CEO	Sell	5,000	$140.47	$702,350.00	340,106
3/26/2018	Jonathan D. Porter	SVP	Sell	150	$141.00	$21,150.00
3/2/2018	Bradford Kyle Armbrester	SVP	Sell	2,235	$138.70	$309,994.50	10,146
3/2/2018	Timothy John O'brien	CMO	Sell	3,064	$137.27	$420,595.28	11,320
3/1/2018	Daniel P Haley	Insider	Sell	1,153	$136.83	$157,764.99	12,436
3/1/2018	Jonathan Bush	CEO	Sell	250	$139.27	$34,817.50	321,533
2/27/2018	Jeffrey R. Immelt	Director	Buy	3,600	$141.04	$507,744.00
2/27/2018	Jonathan Bush	CEO	Sell	4,750	$141.11	$670,272.50	320,557
2/26/2018	Jonathan D. Porter	SVP	Sell	150	$139.87	$20,980.50
2/20/2018	Jeffrey R Immelt	Director	Buy	7,200	$138.44	$996,768.00	678
2/5/2018	Jonathan Bush	CEO	Sell	25,000	$145.00	$3,625,000.00
2/2/2018	Brandon H Hull	Director	Sell	653	$133.00	$86,849.00	5,230
2/1/2018	Jonathan Bush	CEO	Sell	5,000	$122.69	$613,450.00	320,807
1/26/2018	Jonathan D. Porter	SVP	Sell	150	$128.26	$19,239.00
1/2/2018	David Eric Robinson	Director	Sell	5,000	$133.94	$669,700.00	8,596
12/29/2017	Jonathan D Porter	SVP	Sell	150	$134.52	$20,178.00
12/29/2017	Jonathan D. Porter	SVP	Sell	150	$134.52	$20,178.00
12/26/2017	Amy Abernethy	Director	Sell	500	$134.18	$67,090.00	4,045
12/26/2017	Amy Abernethy	Director	Sell	500	$134.18	$67,090.00	4,045
12/26/2017	Jonathan Bush	CEO	Sell	30,000	$134.80	$4,044,000.00	320,807
12/26/2017	Jonathan Bush	CEO	Sell	30,000	$134.80	$4,044,000.00	320,807
12/1/2017	Brandon H. Hull	Director	Sell	800	$132.97	$106,376.00
11/20/2017	Brandon H. Hull	Director	Sell	800	$130.00	$104,000.00
10/27/2017	Bradford Kyle Armbrester	SVP	Sell	1,000	$128.56	$128,560.00
10/20/2017	Brandon H. Hull	Director	Sell	800	$130.00	$104,000.00
10/2/2017	Daniel P Haley	Insider	Sell	1,583	$124.56	$197,178.48	13,408
10/2/2017	Jonathan Bush	CEO	Sell	4,000	$124.17	$496,680.00	319,807
9/15/2017	Jonathan D. Porter	SVP	Sell	300	$130.38	$39,114.00
9/1/2017	Brandon H. Hull	Director	Sell	800	$140.95	$112,760.00
9/1/2017	Jonathan Bush	CEO	Sell	4,000	$139.77	$559,080.00	319,807
8/15/2017	Jonathan D. Porter	SVP	Sell	300	$142.88	$42,864.00
8/1/2017	Brandon H. Hull	Director	Sell	800	$140.01	$112,008.00
8/1/2017	Jonathan Bush	CEO	Sell	4,000	$143.31	$573,240.00	319,807
7/21/2017	Jonathan D. Porter	SVP	Sell	422	$154.00	$64,988.00
7/17/2017	Jonathan D. Porter	SVP	Sell	300	$143.13	$42,939.00
7/3/2017	Brandon H. Hull	Director	Sell	800	$140.81	$112,648.00
7/3/2017	Jonathan Bush	CEO	Sell	4,000	$140.52	$562,080.00	319,807
6/15/2017	Jonathan D. Porter	SVP	Sell	300	$142.27	$42,681.00
6/5/2017	Karl Stubelis	CFO	Sell	3,952	$138.98	$549,248.96	21,810
5/18/2017	Bradford Kyle Armbrester	SVP	Sell	2,431	$130.00	$316,030.00
5/18/2017	Brandon H. Hull	Director	Sell	1,600	$130.00	$208,000.00
5/18/2017	Jonathan Bush	CEO	Sell	4,000	$125.85	$503,400.00	319,807
5/15/2017	Jonathan D. Porter	SVP	Sell	300	$109.48	$32,844.00
4/25/2017	Jonathan Bush	CEO	Sell	8,000	$120.00	$960,000.00	319,807
1/27/2017	John A Kane	Director	Sell	2,875	$123.11	$353,941.25	8,958
1/12/2017	Jonathan Bush	CEO	Sell	4,000	$120.00	$480,000.00	312,109
12/15/2016	Amy Abernethy	Director	Sell	1,000	$117.15	$117,150.00	2,649
12/15/2016	Ed Park	COO	Sell	2,500	$117.15	$292,875.00	13,219
12/15/2016	Jonathan Bush	CEO	Sell	8,000	$120.00	$960,000.00	312,109
12/1/2016	Ed Park	COO	Sell	1,500	$94.60	$141,900.00	10,719
10/27/2016	John A. Kane	Director	Sell	5,750	$122.63	$705,122.50
10/10/2016	Bradford Kyle Armbrester	SVP	Sell	2,545	$130.00	$330,850.00
10/10/2016	Brandon H Hull	Director	Sell	2,400	$130.00	$312,000.00	3,987
10/3/2016	Daniel P Haley	SVP	Sell	2,109	$124.43	$262,422.87	3,195
10/3/2016	Jonathan Bush	CEO	Sell	4,000	$124.34	$497,360.00	312,109
9/7/2016	Karl Stubelis	VP	Sell	928	$123.36	$114,478.08	1,375
8/15/2016	Ed Park	COO	Sell	4,000	$124.20	$496,800.00	20,719
8/1/2016	Jonathan Bush	CEO	Sell	4,000	$128.19	$512,760.00	312,109
7/27/2016	John A Kane	Director	Sell	2,875	$128.81	$370,328.75	10,708
7/6/2016	Ed Park	COO	Sell	1,500	$136.85	$205,275.00	18,819
7/1/2016	Brandon H Hull	Director	Sell	800	$137.48	$109,984.00	6,387
7/1/2016	Jonathan Bush	CEO	Sell	4,000	$138.21	$552,840.00	312,109
6/2/2016	Brandon H Hull	Director	Sell	800	$130.00	$104,000.00	7,187
6/1/2016	Ed Park	COO	Sell	1,500	$125.82	$188,730.00	19,819
6/1/2016	Jonathan Bush	CEO	Sell	4,000	$125.97	$503,880.00	312,109
5/4/2016	Ed Park	COO	Sell	1,500	$127.81	$191,715.00	21,819
5/2/2016	Brandon H Hull	Director	Sell	800	$132.74	$106,192.00	7,987
5/2/2016	Jonathan Bush	CEO	Sell	4,000	$132.09	$528,360.00	312,109
5/2/2016	Kristi Ann Matus	EVP	Sell	415	$133.27	$55,307.05	34,116
4/25/2016	Karl Stubelis	VP	Sell	547	$138.64	$75,836.08
4/6/2016	Ed Park	COO	Sell	1,500	$139.15	$208,725.00	22,919
4/1/2016	Brandon H Hull	Director	Sell	800	$137.72	$110,176.00	8,787
4/1/2016	Jonathan Bush	CEO	Sell	4,000	$138.44	$553,760.00	307,408
4/1/2016	Kristi Ann Matus	EVP	Sell	415	$138.61	$57,523.15	34,531
3/3/2016	Bradford Kyle Armbrester	SVP	Sell	1,369	$132.04	$180,762.76
3/1/2016	Brandon H Hull	Director	Sell	1,600	$130.00	$208,000.00	8,687
3/1/2016	Daniel P Haley	SVP	Sell	1,279	$130.64	$167,088.56	365
3/1/2016	Ed Park	COO	Sell	1,500	$131.66	$197,490.00	26,270
3/1/2016	Jonathan Bush	CEO	Sell	4,000	$129.61	$518,440.00	312,109
3/1/2016	Kristi Ann Matus	EVP	Sell	415	$129.53	$53,754.95	33,357
3/1/2016	Timothy John O'brien	CMO	Sell	846	$132.25	$111,883.50	62
2/16/2016	Bradford Kyle Armbrester	SVP	Sell	1,657	$127.11	$210,621.27	2,500
2/16/2016	Timothy John O'brien	CMO	Sell	816	$127.08	$103,697.28	1,250
2/3/2016	Ed Park	COO	Sell	1,500	$140.61	$210,915.00	27,433
2/1/2016	Jonathan Bush	CEO	Sell	4,000	$140.14	$560,560.00	308,109
2/1/2016	Kristi Ann Matus	EVP	Sell	415	$141.08	$58,548.20	33,772
1/27/2016	John A. Kane	Director	Sell	2,875	$140.81	$404,828.75	6,133
1/6/2016	Ed Park	COO	Sell	1,500	$161.89	$242,835.00	28,933
1/4/2016	Jonathan Bush	CEO	Sell	4,000	$156.79	$627,160.00	308,109
1/4/2016	Kristi Ann Matus	EVP	Sell	415	$159.06	$66,009.90	34,187
12/2/2015	Ed Park	COO	Sell	1,500	$166.81	$250,215.00	30,433
11/20/2015	Stephen N Kahane	EVP	Sell	1,280	$157.80	$201,984.00	17,829
11/6/2015	Stephen N Kahane	EVP	Sell	5,000	$159.51	$797,550.00	19,109
11/4/2015	Ed Park	COO	Sell	1,500	$162.32	$243,480.00	31,933
11/3/2015	Jonathan Bush	CEO	Sell	14,750	$156.50	$2,308,375.00	311,234
10/27/2015	John A. Kane	Director	Sell	2,875	$150.44	$432,515.00	6,133
10/23/2015	Jonathan Bush	CEO	Sell	20,000	$157.50	$3,150,000.00	311,234
10/23/2015	Robert Cosinuke	CMO	Sell	1,211	$159.02	$192,573.22	40,322
10/23/2015	Stephen N Kahane	EVP	Sell	5,000	$150.50	$752,500.00	24,109
10/20/2015	Stephen N Kahane	EVP	Sell	2,000	$132.88	$265,760.00	29,109
10/7/2015	Ed Park	COO	Sell	1,500	$134.23	$201,345.00	33,433
10/2/2015	Jonathan Bush	CEO	Sell	1,000	$130.74	$130,740.00	311,234
9/15/2015	Stephen N Kahane	EVP	Sell	2,000	$135.77	$271,540.00	31,031
9/2/2015	Ed Park	COO	Sell	1,500	$129.64	$194,460.00	34,933
9/2/2015	Jonathan Bush	CEO	Sell	1,000	$131.09	$131,090.00	311,234
8/18/2015	Stephen N Kahane	EVP	Sell	2,000	$141.49	$282,980.00
7/24/2015	David Eric Robinson	Director	Sell	10,000	$130.00	$1,300,000.00
7/21/2015	Stephen N Kahane	EVP	Sell	2,000	$117.32	$234,640.00
7/2/2015	Jonathan Bush	CEO	Sell	1,000	$114.17	$114,170.00
6/2/2015	Jonathan Bush	CEO	Sell	1,000	$115.32	$115,320.00
4/27/2015	John A Kane	Director	Sell	2,875	$125.35	$360,381.25
4/14/2015	Karl Stubelis	VP	Sell	1,115	$126.28	$140,802.20
4/2/2015	Jonathan Bush	CEO	Sell	1,000	$118.77	$118,770.00
3/10/2015	James L Mann	Director	Sell	13,106	$121.27	$1,589,364.62
3/3/2015	Robert Cosinuke	CMO	Sell	6,000	$128.15	$768,900.00
2/24/2015	Jonathan Bush	CEO	Sell	2,499	$130.23	$325,444.77
2/18/2015	Jonathan Bush	CEO	Sell	2,498	$132.04	$329,835.92
2/10/2015	Jonathan Bush	CEO	Sell	7,495	$135.82	$1,017,970.90
2/5/2015	David Eric Robinson	Director	Sell	25,000	$143.17	$3,579,250.00
2/3/2015	Robert Cosinuke	CMO	Sell	6,000	$139.06	$834,360.00
1/5/2015	David Eric Robinson	Director	Sell	25,000	$145.14	$3,628,500.00
1/5/2015	Robert Cosinuke	CMO	Sell	6,000	$145.18	$871,080.00
12/22/2014	Robert Cosinuke	CMO	Sell	6,000	$139.32	$835,920.00
12/2/2014	Jonathan Bush	CEO	Sell	1,000	$116.55	$116,550.00
10/10/2014	Robert Cosinuke	CMO	Sell	3,000	$123.78	$371,340.00
10/2/2014	Jonathan Bush	CEO	Sell	1,000	$128.41	$128,410.00
9/10/2014	Robert Cosinuke	CMO	Sell	6,000	$138.08	$828,480.00
8/11/2014	Robert Cosinuke	CMO	Sell	6,000	$129.43	$776,580.00
8/4/2014	Jonathan Bush	CEO	Sell	1,000	$121.58	$121,580.00
7/10/2014	Robert Cosinuke	CMO	Sell	6,000	$120.10	$720,600.00
7/2/2014	Jonathan Bush	CEO	Sell	1,000	$129.45	$129,450.00
7/1/2014	Stephen N Kahane	Insider	Sell	5,000	$127.60	$638,000.00
6/12/2014	David Eric Robinson	Director	Sell	30,000	$124.12	$3,723,600.00
6/10/2014	Robert Cosinuke	CMO	Sell	6,000	$125.07	$750,420.00
6/2/2014	Jonathan Bush	CEO	Sell	1,000	$125.82	$125,820.00
6/2/2014	Stephen N Kahane	Insider	Sell	5,000	$126.42	$632,100.00
5/2/2014	Jonathan Bush	CEO	Sell	1,000	$123.21	$123,210.00	311,234
5/1/2014	Stephen Kahane	Insider	Sell	5,000	$121.96	$609,800.00	64,285
4/16/2014	Stephen Kahane	Insider	Sell	10,000	$143.96	$1,439,600.00	69,285
4/14/2014	David Eric Robinson	Director	Sell	60,000	$140.61	$8,436,600.00	3,692
4/10/2014	Robert Cosinuke	CMO	Sell	6,000	$151.14	$906,840.00	44,804
4/2/2014	Jonathan Bush	CEO	Sell	1,000	$161.74	$161,740.00	311,234
3/10/2014	Robert Cosinuke	CMO	Sell	6,000	$181.60	$1,089,600.00	46,277
2/18/2014	Timothy Adams	CFO	Sell	30,000	$194.58	$5,837,400.00	40,327
2/12/2014	Dev Ittycheria	Director	Sell	2,000	$181.17	$362,340.00	8,574
2/10/2014	Robert Cosinuke	CMO	Sell	6,000	$172.72	$1,036,320.00	53,321
2/3/2014	Daniel Orenstein	SVP	Sell	1,000	$146.73	$146,730.00	31,262
2/3/2014	David Eric Robinson	Director	Sell	4,000	$146.86	$587,440.00	2,058
1/10/2014	Robert Cosinuke	CMO	Sell	6,000	$132.92	$797,520.00	53,321
1/3/2014	David Eric Robinson	Director	Sell	4,000	$131.86	$527,440.00	2,058
12/10/2013	Robert Cosinuke	CMO	Sell	6,000	$132.77	$796,620.00	53,321
12/3/2013	David Eric Robinson	Director	Sell	4,000	$132.48	$529,920.00	2,058
12/2/2013	Jonathan Bush	CEO	Sell	1,000	$132.24	$132,240.00	311,759
11/4/2013	David Eric Robinson	Director	Sell	4,000	$137.26	$549,040.00
11/4/2013	Jonathan Bush	CEO	Sell	1,000	$137.26	$137,260.00
11/1/2013	Daniel H Orenstein	SVP	Sell	1,000	$133.15	$133,150.00
10/21/2013	Timothy M Adams	CFO	Sell	20,000	$138.39	$2,767,800.00
10/18/2013	Ed Park	COO	Sell	10,021	$123.36	$1,236,190.56
10/18/2013	Jonathan Bush	CEO	Sell	20,000	$120.00	$2,400,000.00
10/10/2013	Robert Cosinuke	CMO	Sell	6,000	$108.21	$649,260.00	53,321
10/3/2013	David Eric Robinson	Director	Sell	4,000	$111.01	$444,040.00
10/2/2013	Jonathan Bush	CEO	Sell	1,000	$110.16	$110,160.00
9/10/2013	Robert Cosinuke	CMO	Sell	6,000	$109.68	$658,080.00
9/3/2013	Daniel Orenstein	SVP	Sell	1,000	$106.73	$106,730.00	31,262
9/3/2013	David Eric Robinson	Director	Sell	4,000	$106.53	$426,120.00	2,058
9/3/2013	Jonathan Bush	CEO	Sell	22,105	$106.45	$2,353,077.25	302,231
8/19/2013	John Kane	Director	Sell	2,000	$111.23	$222,460.00	5,052
8/15/2013	John Kane	Director	Sell	5,000	$110.03	$550,150.00	5,052
8/12/2013	Robert Cosinuke	CMO	Sell	6,000	$115.72	$694,320.00	53,321
8/5/2013	David Eric Robinson	Director	Sell	4,000	$114.01	$456,040.00
8/1/2013	Daniel H Orenstein	SVP	Sell	1,000	$113.73	$113,730.00
8/1/2013	Jonathan Bush	CEO	Sell	5,000	$113.94	$569,700.00	302,231
7/12/2013	Timothy M Adams	CFO	Sell	10,000	$106.14	$1,061,400.00
7/11/2013	David Eric Robinson	Director	Sell	4,000	$90.00	$360,000.00
7/10/2013	Robert Cosinuke	CMO	Sell	6,000	$87.06	$522,360.00
7/1/2013	Daniel H Orenstein	SVP	Sell	1,000	$85.01	$85,010.00
7/1/2013	Jonathan Bush	CEO	Sell	5,000	$85.39	$426,950.00
6/17/2013	David Eric Robinson	Director	Sell	4,000	$90.00	$360,000.00
6/10/2013	Robert Cosinuke	CMO	Sell	6,000	$85.74	$514,440.00
6/3/2013	Daniel H Orenstein	SVP	Sell	1,000	$84.22	$84,220.00
6/3/2013	Jonathan Bush	CEO	Sell	5,000	$84.39	$421,950.00
5/10/2013	Robert Cosinuke	CMO	Sell	6,000	$84.80	$508,800.00
5/1/2013	Jonathan Bush	CEO	Sell	5,000	$95.70	$478,500.00
2/26/2013	David Eric Robinson	Director	Sell	10,000	$90.13	$901,300.00
8/10/2012	Robert Cosinuke	CMO	Sell	3,000	$92.35	$277,050.00

(Data available from 1/1/2013 forward)

athenahealth (NASDAQ ATHN) News Headlines

Source:

Date	Headline
	3 Things You Should Know About Today's Top Entrepreneurs www.fool.com - April 22 at 6:42 PM
	athenahealth (ATHN) Cut to "Hold" at BidaskClub www.americanbankingnews.com - April 19 at 11:52 PM
	athenahealth (ATHN) Rating Lowered to Sell at BidaskClub www.americanbankingnews.com - April 19 at 11:03 AM
	Can Business Services Aid athenahealth's (ATHN) Q1 Earnings? www.zacks.com - April 19 at 8:04 AM
	athenahealth (ATHN) Scheduled to Post Earnings on Wednesday www.americanbankingnews.com - April 18 at 2:48 AM
	athenahealth (ATHN) Rating Reiterated by SunTrust Banks www.americanbankingnews.com - April 17 at 10:21 PM
	Simple Interact Partners with athenahealth's 'More Disruption Please' Program www.benzinga.com - April 17 at 6:08 PM
	athenahealth (ATHN) Downgraded by First Analysis www.americanbankingnews.com - April 16 at 10:54 PM
	athenahealth (ATHN) Lifted to "Hold" at ValuEngine www.americanbankingnews.com - April 16 at 7:35 PM
	Should You Buy athenahealth Inc (NASDAQ:ATHN) When Insiders Do? finance.yahoo.com - April 16 at 5:38 PM
	athenahealth (ATHN) Downgraded by Cowen www.americanbankingnews.com - April 15 at 9:43 AM
	athenahealth (ATHN) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 14 at 6:23 PM
	athenahealth, Inc (ATHN) Expected to Post Quarterly Sales of $318.72 Million www.americanbankingnews.com - April 13 at 4:31 AM
	Edited Transcript of ATHN presentation 8-Mar-17 2:15pm GMT finance.yahoo.com - April 12 at 5:54 PM
	$0.74 Earnings Per Share Expected for athenahealth, Inc (ATHN) This Quarter www.americanbankingnews.com - April 11 at 8:23 AM
	athenahealth (ATHN) Rating Increased to Equal Weight at First Analysis www.americanbankingnews.com - April 6 at 11:31 AM
	Jellyfish Health Partners with athenahealth's 'More Disruption Please' Program to Deliver the Ultimate Patient Experience www.prnewswire.com - April 5 at 5:28 PM
	athenahealth's (ATHN) Buy Rating Reiterated at SunTrust Banks www.americanbankingnews.com - April 5 at 2:17 PM
	Form 4 ATHENAHEALTH INC For: Apr 02 Filed by: Bush Jonathan www.streetinsider.com - April 5 at 9:51 AM
	athenahealth, Inc (ATHN) CEO Sells $702,350.00 in Stock www.americanbankingnews.com - April 4 at 10:38 PM
	Einhorn Isn’t Mystified Nor Befuddled By Greenlight Capital’s Large Losses finance.yahoo.com - April 4 at 4:25 PM
	Commentary: Why We Need to Give Doctors Time to Listen finance.yahoo.com - April 3 at 8:07 AM
	athenahealth Announces First Quarter 2018 Earnings Conference Call finance.yahoo.com - April 2 at 5:38 PM
	athenahealth, Inc (ATHN) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - April 1 at 11:38 AM
	athenahealth (ATHN) Downgraded to "Sell" at BidaskClub www.americanbankingnews.com - March 28 at 12:34 AM
	athenahealth, Inc (ATHN) SVP Sells $21,150.00 in Stock www.americanbankingnews.com - March 27 at 11:14 PM
	$318.72 Million in Sales Expected for athenahealth, Inc (ATHN) This Quarter www.americanbankingnews.com - March 27 at 5:56 AM
	athenahealth (ATHN) Downgraded by ValuEngine to "Sell" www.americanbankingnews.com - March 25 at 8:45 PM
	Zacks: Brokerages Expect athenahealth, Inc (ATHN) to Post $0.74 EPS www.americanbankingnews.com - March 25 at 8:48 AM
	athenahealth (ATHN) Coverage Initiated at Bank of America www.americanbankingnews.com - March 24 at 9:28 PM
	Wright Medical (WMGI) Poised on Acquisitions Amid Forex Woes - Nasdaq www.nasdaq.com - March 22 at 8:10 AM
	Here's Why You Should Invest in Baxter International Now - Nasdaq www.nasdaq.com - March 21 at 8:22 AM
	DocSpera Partners with athenahealth's 'More Disruption Please' Program to Streamline Pre- and Post-Operative Coordination and Improve Decision Support www.prnewswire.com - March 20 at 8:12 AM
	What's Driving Orthofix International to a New 52-Week High - Nasdaq www.nasdaq.com - March 20 at 8:10 AM
	athenahealth, Inc (ATHN) Expected to Announce Quarterly Sales of $318.72 Million www.americanbankingnews.com - March 10 at 11:23 AM
	$0.73 EPS Expected for athenahealth, Inc (ATHN) This Quarter www.americanbankingnews.com - March 8 at 1:08 AM
	athenahealth, Inc (ATHN) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - March 7 at 11:15 AM
	3 Reasons Why You Should Invest in athenahealth (ATHN) Stock - Nasdaq www.nasdaq.com - March 7 at 8:04 AM
	athenahealth, Inc (ATHN) Holdings Cut by Avalon Global Asset Management LLC www.americanbankingnews.com - March 6 at 4:42 AM
	Jonathan Bush Sells 250 Shares of athenahealth, Inc (ATHN) Stock www.americanbankingnews.com - March 5 at 7:54 PM
	athenahealth, Inc (ATHN) Insider Sells $157,764.99 in Stock www.americanbankingnews.com - March 5 at 7:16 PM
	Bradford Kyle Armbrester Sells 2,235 Shares of athenahealth, Inc (ATHN) Stock www.americanbankingnews.com - March 5 at 7:00 PM
	Insider Selling: athenahealth, Inc (ATHN) CMO Sells 3,064 Shares of Stock www.americanbankingnews.com - March 5 at 6:40 PM
	Gagnon Securities LLC Grows Position in athenahealth, Inc (ATHN) www.americanbankingnews.com - March 3 at 5:10 PM
	athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from ... - GlobeNewswire (press release) globenewswire.com - March 2 at 8:04 AM
	athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from Administrative Burden finance.yahoo.com - March 1 at 6:01 PM
	athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from Administrative Burden finance.yahoo.com - March 1 at 6:01 PM
	Jackson Square Partners LLC Buys 5,811 Shares of athenahealth, Inc (ATHN) www.americanbankingnews.com - March 1 at 12:48 PM
	athenahealth, Inc (ATHN) Stake Increased by California Public Employees Retirement System www.americanbankingnews.com - March 1 at 5:38 AM
	Allianz Asset Management GmbH Increases Position in athenahealth, Inc (ATHN) www.americanbankingnews.com - March 1 at 4:20 AM

athenahealth (NASDAQ:ATHN) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

athenahealth (NASDAQ:ATHN) Income Statement, Balance Sheet and Cash Flow Statement

athenahealth (NASDAQ ATHN) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff